| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |